ENTX
NASDAQ · Biotechnology
Entera Bio Ltd
$3.15
-0.07 (-2.17%)
Open$3.23
Previous Close$3.22
Day High$3.28
Day Low$3.12
52W High$4.20
52W Low$0.91
Volume—
Avg Volume228.6K
Market Cap539.16M
P/E Ratio—
EPS$-0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,283.2% upside
Current
$3.15
$3.15
Target
$43.57
$43.57
$34.30
$43.57 avg
$49.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 157.5K | 229.6K | 9.20M |
| Net Income | -43,342,822 | -56,847,187 | -2,830,498 |
| Profit Margin | -27,235.7% | -25,873.9% | -30.8% |
| EBITDA | -43,570,389 | -60,320,416 | -2,581,372 |
| Free Cash Flow | — | — | -3,568,526 |
| Rev Growth | -31.4% | -31.4% | +9.2% |
| Debt/Equity | — | — | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |